Packed red blood cell transfusion in preterm infants. Issue 8 (August 2022)

• Record Type: Journal Article
• Authors: Bellach, Luise; Eigenschink, Michael; Hassanein, Abtin; Savran, Danylo; Salzer, Ulrich; Müllner, Ernst W; Repa, Andreas; Klebermass-Schrehof, Katrin; Wisgrill, Lukas; Giordano, Vito; Berger, Angelika
• Is Part Of: Lancet. Volume 9:Issue 8(2022)
• Page Start: e615
• Page End: e626
• Publication Date: 2022-08
• Subjects: Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15005
• DOI: 10.1016/S2352-3026(22)00207-1
• Languages: English
• ISSNs: 2352-3026

Abstract

Summary: Premature infants commonly receive adult packed red blood cells (pRBCs) during their hospital stay. As adult erythrocytes differ substantially from those of preterm infants, transfusion of adult pRBCs into preterm infants can be considered inappropriate for the physiology of a preterm infant. An absence of standardisation of transfusion protocols makes it difficult to compare and interpret pertinent clinical data, as reflected by unclear associations between pRBC transfusion and complications related to prematurity, such as bronchopulmonary dysplasia, neurodevelopmental impairment, retinopathy of prematurity, or necrotising enterocolitis. The difficulty in interpreting clinical data is further increased by differences in study designs that either overestimate pRBC-associated complications of prematurity or have not yet been designed to directly link pRBC transfusions to their respective complications. Thus, neonatal transfusion practice has become an ongoing difficulty, in which differences in transfusion guidelines hinder the ability to generate comparable clinical data, and heterogeneity in clinical data prevents the implementation of standardised transfusion protocols. To overcome these issues, novel approaches with biochemical-clinical translational designs could enable clinicians to gather causal evidence instead of circumstantial correlation.